Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
NAYYAR SANDEEP
  2. Issuer Name and Ticker or Trading Symbol
APPLERA CORP [ABI/CRA]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Assistant Controller
(Last)
(First)
(Middle)
APPLERA CORP - APPLIED BIOSYSTEMS GROUP, 850 LINCOLN CENTRE DRIVE
3. Date of Earliest Transaction (Month/Day/Year)
11/06/2006
(Street)

FOSTER CITY, CA 94404
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Applied Biosystems Group Common Stock 11/06/2006   M   5,000 A $ 15.54 10,578.2615 D  
Applied Biosystems Group Common Stock 11/06/2006   M   12,500 A $ 20.185 23,078.2615 D  
Applied Biosystems Group Common Stock 11/06/2006   M   11,250 A $ 21.475 34,328.2615 D  
Applied Biosystems Group Common Stock 11/06/2006   S   6,250 D $ 37.95 28,078.2615 D  
Applied Biosystems Group Common Stock 11/06/2006   S   5,000 D $ 37.85 23,078.2615 D  
Applied Biosystems Group Common Stock 11/06/2006   S   12,500 D $ 37.65 10,578.2615 D  
Applied Biosystems Group Common Stock 11/06/2006   S   500 D $ 37.54 10,078.2615 D  
Applied Biosystems Group Common Stock 11/06/2006   S   700 D $ 37.52 9,378.2615 D  
Applied Biosystems Group Common Stock 11/06/2006   S   3,800 D $ 37.5 5,578.2615 D  
Applied Biosystems Group Common Stock 11/07/2006   M   1,900 A $ 33.055 7,478.2615 D  
Applied Biosystems Group Common Stock 11/07/2006   S   100 D $ 38.45 7,378.2615 D  
Applied Biosystems Group Common Stock 11/07/2006   S   200 D $ 38.43 7,178.2615 D  
Applied Biosystems Group Common Stock 11/07/2006   S   200 D $ 38.42 6,978.2615 D  
Applied Biosystems Group Common Stock 11/07/2006   S   1,400 D $ 38.41 5,578.2615 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Applied Biosystems Group Employee Stock Options-Right to Buy $ 15.54 11/06/2006   M     5,000 03/24/2006 03/24/2013 Applied Biosystems Group Common Stock 5,000 $ 15.54 0 D  
Applied Biosystems Group Employee Stock Options-Right to Buy $ 20.185 11/06/2006   M     12,500   (1) 06/17/2014 Applied Biosystems Group Common Stock 12,500 $ 20.185 12,500 D  
Applied Biosystems Group Employee Stock Options-Right to Buy $ 21.475 11/06/2006   M     11,250 06/02/2005(2) 06/02/2015 Applied Biosystems Group Common Stock 11,250 $ 21.475 33,750 D  
Applied Biosystems Group Employee Stock Options-Right to Buy $ 33.055 11/07/2006   M     1,900   (3) 11/15/2011 Applied Biosystems Group Common Stock 1,900 $ 33.055 33,100 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
NAYYAR SANDEEP
APPLERA CORP - APPLIED BIOSYSTEMS GROUP
850 LINCOLN CENTRE DRIVE
FOSTER CITY, CA 94404
      Assistant Controller  

Signatures

 /s/ Thomas P. Livingston, Attorney-In-Fact for Sandeep Nayyar   11/08/2006
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) These options originally became exercisable in four equal annual installments, commencing June 17, 2005. Effective January 20, 2005, the vesting of all of these options was accelerated. However, shares received upon the exercise of accelerated options are subject to a restriction on transfer (covering sales, gifts, pledges, and any other method of disposition) that remains in effect until the earlier of the original vesting dates of those options or termination of employment for any reason.
(2) These options are fully vested and exercisable as of the grant date. However, shares acquired upon the exercise of these options are subject to a restriction on transfer (covering sales, gifts, pledges, and any other method of disposition). The transfer restriction will lapse on 25% of the shares covered by the grant on each of the first four anniversaries of the grant date. Also, the transfer restriction will lapse in full upon termination of employment for any reason.
(3) These options originally became exercisable in four equal annual installments, commencing November 15, 2002.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.